Dow Up 2.00% Nasdaq Up 1.66%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM
3.43 Up 0.19(5.71%) Feb 12, 3:59PM EST
Prev Close:3.24
Open:3.32
Bid:3.21 x 1000
Ask:3.75 x 1000
1y Target Est:10.91
Beta:3.17254
Next Earnings Date:25-Feb-16KERX Earnings announcement
Day's Range:3.21 - 3.43
52wk Range:2.80 - 14.89
Volume:914,706
Avg Vol (3m):1,644,350
Market Cap:360.29M
P/E (ttm):N/A
EPS (ttm):-1.25
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for KERX

Comparison

Symbol% ChgMkt Cap
KERXUp 5.71%360.29M
BAXUp 2.03%20.03B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):40.26
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.07
Quarterly EPS Est (Dec-15) :-0.25
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):-0.03

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback